Trexquant Investment LP Horizon Therapeutics Public LTD CO Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $2.1 Million - $2.23 Million	19,610 New	19,610 $2.14 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $1.49 Million - $2.15 Million	-25,369 Reduced 49.31%	26,079 $1.61 Million
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $1.01 Million - $1.48 Million	-12,736 Reduced 19.84%	51,448 $4.1 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $3.78 Million - $4.8 Million	43,688 Added 213.15%	64,184 $6.75 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $2.02 Million - $2.46 Million	20,496 New	20,496 $2.21 Million
Q2 2021 Aug 12, 2021	SELL	$86.24 - $95.92 $1.89 Million - $2.11 Million	-21,973 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $1.58 Million - $2.1 Million	21,973 New	21,973 $2.02 Million
Q1 2020 May 08, 2020	SELL	$24.87 - $38.56 $250,664 - $388,646	-10,079 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$25.43 - $36.67 $256,308 - $369,596	10,079 New	10,079 $365,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.